Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Lly save search
U.S. FDA Approves Jaypirca™ (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Lines of Systemic Therapy, Including a BTK Inhibitor
Published: 2023-01-27 (Crawled : 20:00) - biospace.com/
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: 0.0%
fda for
Lilly Supports Direct Relief's Efforts to Expand Access to Medicines by Improving Cold Chain Capacity
Published: 2023-01-26 (Crawled : 17:00) - biospace.com/
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
capacity direct
UPSHER-SMITH EXPANDS FLUOXETINE PRODUCT LINE TO INCLUDE AN ORAL SOLUTION
Published: 2023-01-26 (Crawled : 17:00) - prnewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
solution
Myocardial Infarction (MI) Market is Projected to Grow at a Minimal CAGR of 1.61% During the Study Period (2019-2032) | Assesses DelveInsight
Published: 2023-01-26 (Crawled : 16:00) - prnewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
study market
Veru to Report Fiscal 2023 First Quarter Financial Results on February 9, 2023
Published: 2023-01-26 (Crawled : 14:00) - globenewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
VERU | News | $5.91 0.0% 1.8M
|
Health Technology
|
| O: 1.31%
H: 0.81%
C: -4.52%
report financial results
AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
Published: 2023-01-26 (Crawled : 12:20) - globenewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
ACIU | $2.33 -2.92% -3.0% 130K
|
Health Technology
|
| O: 14.1%
H: 0.0%
C: -7.34%
aci-24 for vaccine trial alzheimer’s positive aci-24.060 anti-amyloid beta
Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
NVSEF | News 4 d | $90.0 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
VTRS | $11.89 2.15% 2.1% 9.9M
|
Health Technology
|
| O: 0.0%
H: 0.87%
C: 0.69%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
BHC | $8.38 -1.64% 0.0% 4.7M
|
Health Technology
|
| O: 2.77%
H: 3.28%
C: -0.23%
ABBV | News | $146.28 -0.76% 0.06% 4.6M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M
|
Health Technology
|
| O: -1.76%
H: 0.0%
C: 0.0%
leo pharma global report therapeutics psoriasis market
Insights on the Alzheimer's Drugs Global Market to 2027 - Hospital Sector will Capture more Revenue in Upcoming Years
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $97.85 0
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
NVSEF | News 4 d | $90.0 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
PFE | $43.79 -1.04% 0.0% 23M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
GSK | News | $35.3 -0.11% 0.14% 3.5M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
ABT | News | $109.95 -1.01% 0.0% 4.9M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
global alzheimer's market
Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 11.05%
H: 0.0%
C: -9.9%
research
China Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 11.05%
H: 0.0%
C: -9.9%
ABBV | News | $146.28 -0.76% 0.06% 4.6M
|
Health Technology
|
| O: -0.97%
H: 0.53%
C: -0.26%
drug abbvie report china
Global Cybersecurity Market Analysis Report 2022-2027 - Increasing Focus on Solution-centric Security Capabilities and Rising Vulnerabilities on Endpoint Devices
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 11.05%
H: 0.0%
C: -9.9%
ABBV | News | $146.28 -0.76% 0.06% 4.6M
|
Health Technology
|
| O: -0.97%
H: 0.53%
C: -0.26%
SPLK A | $95.27 -0.3% -0.3% 2.3M
|
Technology Services
|
| O: 2.6%
H: 1.85%
C: -0.59%
MSFT | News | $248.16 0.07% 0.06% 26M
|
Technology Services
|
| O: 0.64%
H: 0.6%
C: -0.19%
CYBR | $139.81 0.71% 2.95% 260K
|
Technology Services
|
| O: 3.52%
H: 1.37%
C: 0.01%
CHKP | $128.97 -0.36% -0.36% 420K
|
Technology Services
|
| O: -2.03%
H: 1.12%
C: -0.55%
global report cybersecurity security market
World Connected Logistics Markets Report 2022-2029: Rising Need for Efficient Warehouse Management Driving Growth with Increasing Adoption of IoT and Cloud Technologies
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
IBM | News | $134.39 -0.05% 0.08% 7.9M
|
Technology Services
|
| O: -0.1%
H: 0.0%
C: 0.0%
INFY | $18.66 -1.48% -0.16% 5.4M
|
Technology Services
|
| O: 0.5%
H: 0.0%
C: 0.0%
HON | News | $208.16 -0.57% -0.57% 2.1M
|
Producer Manufacturing
|
| O: 0.77%
H: 1.82%
C: 1.46%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 11.05%
H: 0.0%
C: -9.9%
ABBV | News | $146.28 -0.76% 0.06% 4.6M
|
Health Technology
|
| O: -0.97%
H: 0.53%
C: -0.26%
INTC | News | $28.155 -6.43% -7.46% 150M
|
Electronic Technology
|
| O: 2.13%
H: 0.0%
C: 0.0%
management report for growth iot cloud
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
Published: 2023-01-23 (Crawled : 10:00) - biospace.com/
TAK | News | $16.03 -0.43% 0.0% 3.7M
|
Health Technology
|
| O: 0.25%
H: 0.4%
C: -0.25%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
license china
U.S. Food and Drug Administration Issues Complete Response Letter for Accelerated Approval of Donanemab
Published: 2023-01-19 (Crawled : 00:00) - prnewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
drug for approval response food
Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results Announcement
Published: 2023-01-19 (Crawled : 17:00) - biospace.com/
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
announcement conference for financial results
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
TAK | News | $16.03 -0.43% 0.0% 3.7M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
NVO | $138.09 0.4% 1.38% 1.1M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M
|
Health Technology
|
| O: -1.45%
H: 0.0%
C: 0.0%
GSK | News | $35.3 -0.11% 0.14% 3.5M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
ABBV | News | $146.28 -0.76% 0.06% 4.6M
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
GILD F | $83.7 0.1% 0.1% 4.1M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
global report growth market
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List
Published: 2023-01-19 (Crawled : 04:00) - prnewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
drug approved
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
VTRS | $11.89 2.15% 2.1% 9.9M
|
Health Technology
|
| O: -0.17%
H: 0.25%
C: -2.96%
TMO | News | $573.63 -0.65% -0.03% 1.1M
|
Health Technology
|
| O: 0.56%
H: 0.97%
C: -1.87%
NVO | $138.09 0.4% 1.38% 1.1M
|
Health Technology
|
| O: 0.57%
H: 0.84%
C: -0.01%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 0.08%
H: 0.01%
C: -1.16%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
GSK | News | $35.3 -0.11% 0.14% 3.5M
|
Health Technology
|
| O: -0.03%
H: 0.17%
C: -1.01%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
ABT | News | $109.95 -1.01% 0.0% 4.9M
|
Health Technology
|
| O: -0.16%
H: 0.33%
C: -1.5%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
BIIB A | $290.0 -0.66% -0.66% 890K
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | $65.54 -0.68% -0.69% 3.1M
|
Health Technology
|
| O: 1.36%
H: 0.33%
C: -1.13%
AMGN | News | $253.68 -0.47% -0.47% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -1.87%
for therapy growth
Innovent Announces Inclusion in the China National Reimbursement Drug List (NRDL) of TYVYT in Two New Indications, Olverembatinib for the First Listing, BYVASDA, HALPRYZA and SULINNO in Multiple New Indications
Published: 2023-01-18 (Crawled : 14:20) - biospace.com/
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
INCY | News F | $85.66 -0.41% -0.41% 930K
|
Health Technology
|
| O: -0.21%
H: 1.66%
C: 1.46%
drug tyvyt for china
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
Published: 2023-01-18 (Crawled : 12:20) - globenewswire.com
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
ACIU | $2.33 -2.92% -3.0% 130K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.9%
pi-2620 disease for diagnostic life tau imaging alzheimer’s molecular study
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.